Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin

被引:20
作者
Drieschner, N. [1 ]
Belge, G. [1 ]
Rippe, V. [1 ]
Meiboom, M. [1 ]
Loeschke, S. [1 ]
Bullerdiek, J. [1 ]
机构
[1] Univ Bremen, Ctr Human Genet, D-28359 Bremen, Germany
关键词
D O I
10.1089/thy.2006.16.1091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Epithelial tumors of the thyroid are cytogenetically well-investigated tumors. So far, the main cytogenetic subgroups, characterized by trisomy 7 and by rearrangements of either 19q13 or 2p21, respectively, have been described. Recently, we have been able to describe the involvement of a novel gene called THADA in benign thyroid lesions with 2p21 rearrangements. Other fusion genes found in thyroid lesions are RET/PTC and PAX8/PPAR gamma. The latter occurs in follicular thyroid carcinomas with a t(2;3)(q13;p25). Here we present molecular-cytogenetic and cytogenetic investigations on a follicular thyroid adenoma with a t(2;20;3)(p21;q11.2; p25). In this case, an intronic sequence of PPAR gamma is fused to exon 28 of THADA. We used BAC clones containing the genomic sequence of PPAR gamma for fluorescence in situ hybridization to confirm the localization of the breakpoint within intron 2 of PPAR gamma. Our findings suggest that the close surrounding of PPAR is a breakpoint hot spot region, leading to recurrent alterations of this gene in thyroid tumors of follicular origin including carcinomas as well as adenomas with or without involvement of PAX8.
引用
收藏
页码:1091 / 1096
页数:6
相关论文
共 40 条
  • [1] Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
    Altschul, SF
    Madden, TL
    Schaffer, AA
    Zhang, JH
    Zhang, Z
    Miller, W
    Lipman, DJ
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (17) : 3389 - 3402
  • [2] Fusion genes in solid tumors
    Åman, P
    [J]. SEMINARS IN CANCER BIOLOGY, 1999, 9 (04) : 303 - 318
  • [3] CYTOGENETIC FINDINGS ON 8 FOLLICULAR THYROID ADENOMAS INCLUDING ONE WITH A T(10-19)
    BARTNITZKE, S
    HERRMANN, ME
    LOBECK, H
    ZUSCHNEID, W
    NEUHAUS, P
    BULLERDIEK, J
    [J]. CANCER GENETICS AND CYTOGENETICS, 1989, 39 (01) : 65 - 68
  • [4] EXPRESSION OF SV40 T-ANTIGEN IN LIPOMA CELLS WITH A CHROMOSOMAL TRANSLOCATION T(3-12) IS NOT SUFFICIENT FOR DIRECT IMMORTALIZATION
    BELGE, G
    KAZMIERCZAK, B
    MEYERBOLTE, K
    BARTNITZKE, S
    BULLERDIEK, J
    [J]. CELL BIOLOGY INTERNATIONAL REPORTS, 1992, 16 (04) : 339 - 347
  • [5] BELGE G, 1994, HUM GENET, V94, P198
  • [6] Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology
    Belge, G
    Rogue, L
    Soares, J
    Bruckmann, S
    Thode, B
    Fonseca, E
    Clode, A
    Bartnitzke, S
    Castedo, S
    Bullerdiek, J
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 101 (01) : 42 - 48
  • [7] Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb
    Bol, S
    Belge, G
    Rippe, V
    Bullerdiek, J
    [J]. CYTOGENETICS AND CELL GENETICS, 2001, 95 (3-4): : 189 - 191
  • [8] Structural abnormalities of chromosome 2 in Benign thyroid tumors - Three new cases and review of the literature
    Bol, S
    Belge, G
    Thode, B
    Bartnitzke, S
    Bullerdiek, J
    [J]. CANCER GENETICS AND CYTOGENETICS, 1999, 114 (01) : 75 - 77
  • [9] BONDESON L, 1989, CANCER, V64, P680, DOI 10.1002/1097-0142(19890801)64:3<680::AID-CNCR2820640319>3.0.CO
  • [10] 2-I